Concepedia

Li Chen

LC

15

Publications

588

Citations

12

H-Index

2018

Active since

Affiliations

Fudan University Shanghai Cancer Center(Current)

Jiangsu Hengrui Medicine (China)

Shanghai Medical College of Fudan University

Fujian Medical University

Li Chen is an author at Fudan University Shanghai Cancer Center specializing in medicine, immunology, and oncology.

ORCID

Top concepts

Publications per year

2018–2025

15

Publications

15

Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1–Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial

Qin Xu, Junjie Wang, Yang Sun et al. · Journal of Clinical Oncology · 2022 · 139 citations · Full text

Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial

Song‐Yang Wu, Ying Xu, Li Chen et al. · Molecular Cancer · 2022 · 90 citations · Full text

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Li Chen, Yi‐Zhou Jiang, Song‐Yang Wu et al. · Clinical Cancer Research · 2022 · 89 citations · Full text

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial

Lei Fan, Zhonghua Wang, Linxiaoxi Ma et al. · The Lancet Oncology · 2024 · 55 citations

, , +5

CD8+ T-cell–Mediated Immunoediting Influences Genomic Evolution and Immune Evasion in Murine Gliomas

J. Robert Kane, Junfei Zhao, Takashi Tsujiuchi et al. · Clinical Cancer Research · 2020 · 36 citations · Full text

Rows per page

1–5 of 15